Active suppression induced by cutaneous exposure to bacterial superantigen is prevented by interleukin-12 treatment in vivo.

von Saloga, J, Enk, A H, Becker, D, Bellinghausen, I, Kühn, S, Knop, J
Veröffentlicht 1998

Identification and induction of human keratinocyte-derived IL-12.

von Müller, G, Saloga, J, Germann, T, Bellinghausen, I, Mohamadzadeh, M, Knop, J, Enk, A H
Veröffentlicht 1994

Adjuvant effects of aluminium hydroxide-adsorbed allergens and allergoids – differences in vivo and in vitro

von Heydenreich, B, Bellinghausen, I, Lund, L, Henmar, H, Lund, G, Adler Würtzen, P, Saloga, J
Veröffentlicht 2014